Akcea Therapeutics and Ambry Genetics are partnering to offer no-cost, confidential genetic testing and confidential genetic counseling to patients through the hATTR Compass Genetic Testing Program who are clinically suspected of having hATTR amyloidosis with polyneuropathy as well as individuals with a family history of hATTR amyloidosis.